Intravenous immunoglobulin for the treatment of Kawasaki disease in children
about
Intravenous immunoglobulins for the treatment of infections in patients with haematological cancersSteroid hormone treatment for Kawasaki disease in childrenCorticosteroids for the treatment of Kawasaki disease in childrenIntravenous immunoglobulins for the treatment of infections in patients with haematological cancersSteroid hormone treatment for Kawasaki disease in childrenSalicylate for the treatment of Kawasaki disease in childrenAcute Kawasaki disease: not just for kidsCritical Overview of the Risk Scoring Systems to Predict Non-Responsiveness to Intravenous Immunoglobulin in Kawasaki SyndromeKawasaki Disease: A Clinician's UpdateUse of intravenous immunoglobulin in pediatric practiceIntravenous immunoglobulin as clinical immune-modulating therapy.Recognising Kawasaki disease in UK primary care: a descriptive study using the Clinical Practice Research Datalink.Advances in the use of biologic agents for the treatment of systemic vasculitisWorkshop on use of intravenous immunoglobulin in hand, foot and mouth disease in Southeast Asia.Indications for IVIG in rheumatic diseasesIntravenous immunoglobulin therapy in vasculitic ulcers: a case of polyarteritis nodosa.Genome-Wide Association Study Identifies Novel Susceptibility Genes Associated with Coronary Artery Aneurysm Formation in Kawasaki DiseaseMajor methylation alterations on the CpG markers of inflammatory immune associated genes after IVIG treatment in Kawasaki diseaseDevelopment of coronary artery lesions in indolent Kawasaki disease following initial spontaneous defervescence: a retrospective cohort studyKawasaki disease (syndrome)-our experience-Corticosteroids for the treatment of Kawasaki disease in children.Clinical uses of intravenous immunoglobulin.Epidemiologic survey of Kawasaki disease in Inner Mongolia, China, between 2001 and 2013.Clinical applications of intravenous immunoglobulins (IVIg)--beyond immunodeficiencies and neurology.Potential and Limitations of Cochrane Reviews in Pediatric Cardiology: A Systematic Analysis.Intravenous Immunoglobulin Therapy in Pediatric Narcolepsy: A Nonrandomized, Open-Label, Controlled, Longitudinal Observational Study.Inhibition of human coronavirus NL63 infection at early stages of the replication cycle.Kawasaki disease: always straight to the heart?Th17- and Treg-related cytokine and mRNA expression are associated with acute and resolving Kawasaki disease.Prediction of resistance to standard intravenous immunoglobulin therapy in kawasaki disease.Recommendations for the use of albumin and immunoglobulins.Guidelines for medical treatment of acute Kawasaki disease: report of the Research Committee of the Japanese Society of Pediatric Cardiology and Cardiac Surgery (2012 revised version).TNF-α blockers for the treatment of Kawasaki disease in children
P2860
Q24186274-09E208EA-1652-4A27-9E64-BF2A42574C22Q24194442-5D6213DF-7C1D-4C0B-BE5F-2BEBAA8FF906Q24194653-CB2B9DE6-5012-484B-82C8-4A063B1C73A4Q24236448-C6C1FA89-CEBB-457D-A60C-674E0270BFA4Q24242875-48FC637A-AC37-4000-AF11-7FFE79FFFCA8Q24243818-67F9EA69-C482-4578-9057-C6575394F2E1Q24682484-53FFFB6D-270F-4393-96BC-9C41C398AF54Q26765479-B26E7D3A-042D-4025-8E81-04E6DA328398Q26998791-CE5D98DC-FDB5-4A28-AD01-889A28F9B95AQ27011481-1DDBC2B7-91C2-4309-8060-FB25D2D707A6Q33420267-01996C58-1181-4AC5-988D-8ED2037C2065Q33951717-3B84B5AB-C5E8-4398-8188-D733FC941F57Q34065598-4E217EE5-D578-4939-B374-56EEE63B9530Q34844126-060B3AF8-617E-4056-B103-6271381C07F7Q35102141-04BB8912-428F-4E01-8B6A-582ACCA02113Q35309185-4EAFB96D-CEC9-4206-8453-79AE5FCB5D23Q36015444-0DDD4720-B0E6-4E90-ACE9-9CBE10BC3E1DQ36106176-6929D754-7A37-4308-A8D3-571682DE85D9Q36246685-165E91AA-B139-4654-AF6A-609AA323EE22Q36259694-13C82004-4E4B-4DB7-B413-21270812A4F8Q36262749-6BB8B9A9-F64F-4AB8-A975-38C8F0CCD0BDQ36264883-7BD61D0D-9771-4243-BF6B-CAE192BE0FA7Q37108769-53821913-29CB-411A-8C33-80402D8ED067Q37626123-E91BBB4A-AE25-4EC6-A102-20B9557201EEQ38940637-F0DF46BF-185C-43DD-A605-82913A799CAAQ39016381-3D847E3C-ABD9-497B-B781-DE36B28F2F67Q40275624-333836E8-8834-4A2D-A4D6-BEE241DD191EQ40276542-044054D5-0236-40A3-8C7F-551DFE2C180AQ41546604-F4B8E2A8-D199-492D-931A-CD1A2B9141E6Q41733404-E6583F94-551C-44D8-9133-CD24615AB3DBQ42671923-2E77F3DB-5426-4DD0-B621-CC116A83871EQ54144614-30E9402C-E736-45AA-A467-7D4F10AF658BQ56759657-5096D37C-B572-49C9-810F-35DB46C85861
P2860
Intravenous immunoglobulin for the treatment of Kawasaki disease in children
description
2003 nî lūn-bûn
@nan
2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Intravenous immunoglobulin for the treatment of Kawasaki disease in children
@ast
Intravenous immunoglobulin for the treatment of Kawasaki disease in children
@en
Intravenous immunoglobulin for the treatment of Kawasaki disease in children
@en-gb
Intravenous immunoglobulin for the treatment of Kawasaki disease in children
@nl
type
label
Intravenous immunoglobulin for the treatment of Kawasaki disease in children
@ast
Intravenous immunoglobulin for the treatment of Kawasaki disease in children
@en
Intravenous immunoglobulin for the treatment of Kawasaki disease in children
@en-gb
Intravenous immunoglobulin for the treatment of Kawasaki disease in children
@nl
prefLabel
Intravenous immunoglobulin for the treatment of Kawasaki disease in children
@ast
Intravenous immunoglobulin for the treatment of Kawasaki disease in children
@en
Intravenous immunoglobulin for the treatment of Kawasaki disease in children
@en-gb
Intravenous immunoglobulin for the treatment of Kawasaki disease in children
@nl
P2093
P2860
P3181
P1476
Intravenous immunoglobulin for the treatment of Kawasaki disease in children
@en
P2093
J H Baumer
R M Oates-Whitehead
P2860
P304
P3181
P356
10.1002/14651858.CD004000
P577
2003-01-01T00:00:00Z